Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Illumina — Holy Grail
Entity

Illumina — Holy Grail

Tracked across 3 events · 513 articles · First seen Apr 06, 2026 · Last active Aug 10, 2026

Sentiment
-33
Attention
4
Events
3
Relationships
22
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
4 -80
Regulatory
GRAIL Securities Class Action Lawsuit
Impact: Illumina — Holy Grail is the defendant in the securities class action; its stock dropped over 50% after the NHS-Galleri trial failed to meet its primary endpoint, resulting in a $2.2 billion market cap loss.
Jun 05, 2026 · 315 articles
4 -90
Regulatory
GRAIL Securities Fraud Class Action
Impact: Illumina — Holy Grail is the defendant in multiple securities fraud class actions. The company's stock collapsed 50.55% after its NHS-Galleri trial failed to meet its primary endpoint, erasing over $2.2 billion in market capitalization. The litigation and trial failure severely damage its financial standing and investor trust.
Jun 09, 2026 · 192 articles
4 70
Regulatory
FDA Panel to Review GRAIL Galleri PMA
Illumina — Holy Grail, Inc. announced that the U.S. United States — Food and Drug Administration's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will meet on September 23, 2026, to review…
Impact: Illumina — Holy Grail is the developer of the Galleri test and the primary subject of the FDA review. A positive outcome could lead to market approval, transforming its commercial prospects.
Aug 07, 2026 · 6 articles
Key Actions (3)
90 Illumina — Holy Grail announced FDA panel meeting United States — Food and Drug AdministrationFDA Panel to Review GRAIL...
80 Illumina — Holy Grail submitted PMA application United States — Food and Drug AdministrationFDA Panel to Review GRAIL...
40 United States — Food and Drug Administration designated Breakthrough Device Illumina — Holy GrailFDA Panel to Review GRAIL...
Relationships (22)
The Law Offices of Frank R. Cruz ↔ Illumina — Holy Grail
The Law Offices of Frank R. Cruz ↔ Illumina — Holy Grail
United Kingdom — National Health Service ↔ Illumina — Holy Grail
Reed Kathrein ↔ Illumina — Holy Grail
United Kingdom — National Health Service ↔ Illumina — Holy Grail
Reed Kathrein ↔ Illumina — Holy Grail
Hagens Berman ↔ Illumina — Holy Grail
Hagens Berman ↔ Illumina — Holy Grail
Bleichmar Fonti & Auld LLP ↔ Illumina — Holy Grail
United States — United States District Court for the Northern District of California ↔ Illumina — Holy Grail
Bleichmar Fonti & Auld LLP ↔ Illumina — Holy Grail
United States — United States District Court for the Northern District of California ↔ Illumina — Holy Grail
Glancy Prongay & Murray ↔ Illumina — Holy Grail
Glancy Prongay & Murray ↔ Illumina — Holy Grail
Bronstein, Gewirtz & Grossman, LLC ↔ Illumina — Holy Grail
Bronstein, Gewirtz & Grossman, LLC ↔ Illumina — Holy Grail
Rosen Law Firm ↔ Illumina — Holy Grail
Rosen Law Firm ↔ Illumina — Holy Grail
United States — United States Securities and Exchange Commission ↔ Illumina — Holy Grail
United States — United States Securities and Exchange Commission ↔ Illumina — Holy Grail
United Kingdom ↔ Illumina — Holy Grail
United Kingdom ↔ Illumina — Holy Grail
ERGEN INTELLIGENCE
Track Illumina — Holy Grail live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.